Short answer · Medically reviewed summary · Last updated: 2026-05-08
Achalasia is a rare esophageal motility disorder with an estimated prevalence of approximately 10 per 100,000 individuals worldwide. While incidence rates vary, it is generally considered a rare disease, with roughly 1 new case occurring annually per 100,000 people, though these figures likely underestimate the true burden due to frequent misdiagnosis. What is the prevalence and incidence of Achalasia? Achalasia is categorized as a rare disease.
5 people with Achalasia have shared their first-person experience on this question at DiseaseMaps.
Achalasia is a rare esophageal motility disorder with an estimated prevalence of approximately 10 per 100,000 individuals worldwide. While incidence rates vary, it is generally considered a rare disease, with roughly 1 new case occurring annually per 100,000 people, though these figures likely underestimate the true burden due to frequent misdiagnosis.
Achalasia is categorized as a rare disease. Clinical data, such as that provided by Orphanet, suggests the prevalence is roughly 10 cases per 100,000 population. The incidence of Achalasia is estimated at 1 per 100,000 people per year. However, these numbers are widely viewed as conservative because the condition is often misdiagnosed as gastroesophageal reflux disease (GERD), leading to a significant delay in receiving an accurate diagnosis for many patients.
Achalasia impacts both men and women, with most clinical studies showing an equal gender distribution. While it can occur at any age, the onset of Achalasia is most frequently observed in adults between the ages of 30 and 60. Although pediatric Achalasia exists, it is significantly less common, representing only about 5% of all cases.
Accurate tracking of Achalasia remains difficult for several reasons:
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.